Hmmm...Bid/Ask...oldmanbadman rdncoic
Bid was 1.10 and Ask was 1.15 three minutes ago. Something is going on and the insiders are aware of it. They are buying. Should we be buying? :) :) :) oldmanbadman rdncoic
STRONG BUY!
Bid was 1.10 and Ask was 1.15 three minutes ago. Something is going on and the insiders are aware of it. They are buying. Should we be buying? :) :) :) oldmanbadman rdncoic
STRONG BUY!
Recent BMRA News
- Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026 • GlobeNewswire Inc. • 04/29/2026 12:19:00 PM
- Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway • GlobeNewswire Inc. • 04/16/2026 12:19:00 PM
- Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs • GlobeNewswire Inc. • 04/14/2026 12:19:00 PM
- Biomerica Reports Third Quarter Fiscal 2026 Financial Results • GlobeNewswire Inc. • 04/13/2026 10:57:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/13/2026 09:15:20 PM
- Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe • GlobeNewswire Inc. • 03/18/2026 12:19:00 PM
- Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain • GlobeNewswire Inc. • 03/05/2026 01:19:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/27/2026 10:15:26 PM
- Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy • GlobeNewswire Inc. • 02/26/2026 01:19:00 PM
- Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution • GlobeNewswire Inc. • 02/18/2026 01:19:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 10:40:25 PM
- Biomerica Reports Second Quarter Fiscal 2026 Financial Results • GlobeNewswire Inc. • 01/14/2026 10:17:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/14/2026 10:15:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/31/2025 10:10:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/31/2025 10:10:03 PM
- Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test • GlobeNewswire Inc. • 12/23/2025 01:19:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/16/2025 01:19:33 PM
- Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio • GlobeNewswire Inc. • 12/11/2025 01:08:00 PM
- Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS • GlobeNewswire Inc. • 11/25/2025 01:19:00 PM
- Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand • GlobeNewswire Inc. • 11/06/2025 01:19:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/23/2025 08:15:04 PM
- Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S. • GlobeNewswire Inc. • 10/16/2025 12:19:00 PM
- Biomerica Reports First Quarter Fiscal 2026 Financial Results • GlobeNewswire Inc. • 10/15/2025 01:27:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/14/2025 09:11:06 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/09/2025 09:15:26 PM
